UPDATE : Friday, October 18, 2019
상단여백
Myongji Hospital opens sports medicine center
Myongji Hospital said that it has opened a new sports medicine center at th...
by Lee Han-soo  |  2019-08-06 16:54
라인
Japanese firms fear boycott may hurt prescription drug sales
Korean offshoots of Japanese pharmaceutical companies are worrying that the...
by Kim Yun-mi  |  2019-08-06 15:44
라인
Sillajen cites salvation therapy as reason for trial suspension advice
Sillajen said that it believes that the Independent Data Monitoring Committ...
by Lee Han-soo  |  2019-08-06 15:43
라인
HLB to seek pre-NDA meeting with FDA for rivoceranib
HLB said it would request for a pre-New Drug Application (NDA) meeting with...
by Jeong Sae-im  |  2019-08-06 15:43
라인
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday'
Biopharmaceutical shares in the nation’s secondary bourse had their worst d...
by Lee Han-soo  |  2019-08-06 13:50
라인
Roche, MSD, AstraZeneca: top 3 risers on NASDAQ biotech
Roche, MSD (Merck in the U.S.), and AstraZeneca achieved the most significa...
by Kim Yun-mi  |  2019-08-06 11:29
라인
South Koreans learn to thank life by experiencing death
Some South Koreans are using an unorthodox method to appreciate life and co...
by Lee Han-soo  |  2019-08-06 06:00
라인
Pharmicell submits investigational new drug application for prostate cancer treatment
Pharmicell said that it has filed an investigational new drug application t...
by Lee Han-soo  |  2019-08-05 17:59
라인
Crystal Genomics confirms efficacy of inflammatory bowel disease treatment
Crystal Genomics said that it has confirmed the efficacy of CG-598, an infl...
by Lee Han-soo  |  2019-08-05 17:02
라인
Sillajen’s trouble heralds fall of one of most prominent biotech firms
Shares of Sillajen continued to take a nosedive Monday after the biotech fi...
by Lee Han-soo  |  2019-08-05 16:55
라인
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen
With Japan deciding to remove South Korea from the list of trusted trading ...
by Lee Han-soo  |  2019-08-05 16:01
라인
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
Amgen won the battle against Sanofi in sales of cholesterol-lowering PCSK9 ...
by Kim Yun-mi  |  2019-08-05 15:37
라인
SillaJen remains confident about Pexa-Vec’s value, despite trial failure
SillaJen said Pexa-Vec, an oncolytic viral drug, still had significant pote...
by Jeong Sae-im  |  2019-08-05 14:49
라인
Suspicions resurge over SillaJen execs’ stock selling before Pexa-Vec trial suspension
With the likely suspension of SillaJen’s trial on its major anticancer pipe...
by Jeong Sae-im  |  2019-08-05 11:26
라인
Helixmith unveils results for neuromuscular disease treatment
Helixmith has published a study that confirmed the efficacy of AV6-H’s, a g...
by Lee Han-soo  |  2019-08-02 17:52
라인
Japan’s 'whitelist’ removal to have minimal effect on biopharmaceutical sector
The local biopharmaceutical industry expects that Japan’s decision to remov...
by Lee Han-soo  |  2019-08-02 17:14
라인
‘MSD Korea playing tricks to maintain monitoring on salespersons’
MSD Korea’s labor and management are again in dispute over the so-called “s...
by Kim Yun-mi  |  2019-08-02 15:48
라인
Biotech shares tank amid SillaJen’s likely halt of Pexa-Vec trial
Local biotech shares went down altogether on Friday after SillaJen said it ...
by Jeong Sae-im  |  2019-08-02 15:45
라인
Conflict erupts between employees of Takeda, Shire during merger
Takeda Pharmaceutical Korea’s labor union said Takeda employees faced unfai...
by Kim Yun-mi  |  2019-08-02 14:23
라인
Researchers use ultrasonic wave to charge in-body medical devices
A local research team has succeeded in developing a technology that can cha...
by Lee Han-soo  |  2019-08-02 14:09
여백
여백
여백
Back to Top